Chong Lee Yee, Clarkson Jan E, Dobbyn-Ross Lorna, Bhakta Smriti
UK Cochrane Centre, Oxford, UK.
Cochrane Database Syst Rev. 2014 Nov 28(11):CD005101. doi: 10.1002/14651858.CD005101.pub3.
Slow-release fluoride devices have been investigated as a potentially cost-effective method of reducing dental caries in people with high risk of disease.
To evaluate the effectiveness and safety of different types of slow-release fluoride devices on preventing, arresting, or reversing the progression of carious lesions on all surface types of primary (deciduous) and permanent teeth.
We searched the following electronic databases: the Cochrane Oral Health Group Trials Register (to 13 August 2014), the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 7), MEDLINE via Ovid (1946 to 13 August 2014), and EMBASE via Ovid (1980 to 13 August 2014). We searched the US National Institutes of Health Trials Register and the World Health Organization (WHO) International Clinical Trials Registry Platform. We placed no restrictions on the language or date of publication when searching the electronic databases.We first published the review in 2006. The update in 2013 found 302 abstracts, but none of these met the inclusion criteria of the review.
Parallel randomised controlled trials (RCTs) comparing slow-release fluoride devices with an alternative fluoride treatment, placebo, or no intervention in all age groups. The main outcomes measures sought were changes in numbers of decayed, missing, and filled teeth or surfaces (DMFT/DMFS in permanent teeth or dmft/dmfs in primary teeth), and progression of carious lesions through enamel and into dentine.
We conducted data collection and analysis using standard Cochrane review methods. At least two review authors independently performed all the key steps in the review such as screening of abstracts, application of inclusion criteria, data extraction, and risk of bias assessment. We resolved discrepancies through discussions or arbitration by a third or fourth review author.
We found no evidence comparing slow-release fluoride devices against other types of fluoride therapy.We found only one double-blind RCT involving 174 children comparing a slow-release fluoride device (glass beads with fluoride were attached to buccal surfaces of right maxillary first permanent molar teeth) against control (glass beads without fluoride were attached to buccal surfaces of right maxillary first permanent molar teeth). This study was assessed to be at high risk of bias. The study recruited children from seven schools in an area of deprivation that had low levels of fluoride in the water. The mean age at the beginning of the study was 8.8 years and at the termination was 10.9 years. DMFT in permanent teeth or dmft in primary teeth was greater than one at the start of the study and greater than one million colony-forming units of Streptococcus mutans per millilitre of saliva.Although 132 children were still included in the trial at the two-year completion point, examination and statistical analysis was performed on only the 63 children (31 in intervention group, 32 in control group) who had retained the beads (retention rate was 47.7% at two years). Among these 63 children, caries increment was reported to be statistically significantly lower in the intervention group than in the control group (DMFT: mean difference -0.72, 95% confidence interval (CI) -1.23 to -0.21; DMFS: mean difference -1.52, 95% CI -2.68 to -0.36 (very low quality evidence)). Although this difference was clinically significant, it only holds true for those children who maintain the fluoride beads; over 50% of children did not retain the beads.Harms were not reported within the trial report. Evidence for other outcomes sought in this review (progression to of caries lesion, dental pain, healthcare utilisation data) were also not reported.
AUTHORS' CONCLUSIONS: There is insufficeint evidence to determine the caries-inhibiting effect of slow-release fluoride glass beads. The body of evidence available is of very low quality and there is a potential overestimation of benefit to the average child. The applicability of the findings to the wider population is unclear; the study had included children from a deprived area that had low levels of fluoride in drinking water, and were considered at high risk of carries. In addition, the evidence was only obtained from children who still had the bead attached at two years (48% of all available children); children who had lost their slow-release fluoride devices earlier might not have benefited as much from the devices.
缓释氟化物装置已被作为一种降低高龋齿风险人群龋齿发病率的潜在经济有效的方法进行研究。
评估不同类型的缓释氟化物装置在预防、阻止或逆转乳牙和恒牙所有表面类型龋损进展方面的有效性和安全性。
我们检索了以下电子数据库:Cochrane口腔健康组试验注册库(截至2014年8月13日)、Cochrane对照试验中心注册库(CENTRAL)(2014年第7期)、通过Ovid检索的MEDLINE(1946年至2014年8月13日)以及通过Ovid检索的EMBASE(1980年至2014年8月13日)。我们还检索了美国国立卫生研究院试验注册库和世界卫生组织(WHO)国际临床试验注册平台。在检索电子数据库时,我们对语言或出版日期没有限制。本综述首次发表于2006年。2013年的更新检索到302篇摘要,但这些摘要均未符合本综述的纳入标准。
平行随机对照试验(RCT),比较缓释氟化物装置与其他氟化物治疗、安慰剂或在所有年龄组中不进行干预的情况。主要的结局指标为龋失补牙数或龋失补牙面数(恒牙为DMFT/DMFS,乳牙为dmft/dmfs)的变化,以及龋损从釉质进展到牙本质的情况。
我们采用标准的Cochrane综述方法进行数据收集和分析。至少两名综述作者独立完成综述中的所有关键步骤,如摘要筛选、纳入标准应用、数据提取和偏倚风险评估。我们通过讨论或由第三位或第四位综述作者进行仲裁来解决分歧。
我们没有找到比较缓释氟化物装置与其他类型氟化物治疗的证据。我们仅发现一项涉及174名儿童的双盲RCT,该试验比较了一种缓释氟化物装置(将含氟玻璃珠附着于右上颌第一恒磨牙的颊面)与对照组(将不含氟的玻璃珠附着于右上颌第一恒磨牙的颊面)。该研究被评估为存在高偏倚风险。该研究从一个贫困地区的七所学校招募儿童,该地区水中氟含量较低。研究开始时的平均年龄为8.8岁,结束时为10.9岁。在研究开始时,恒牙的DMFT或乳牙的dmft大于1,且每毫升唾液中变形链球菌的菌落形成单位大于100万。尽管在两年结束时仍有132名儿童纳入试验,但仅对保留了珠子的63名儿童(干预组31名,对照组32名)进行了检查和统计分析(两年时的保留率为47.7%)。在这63名儿童中,据报道干预组的龋病增量在统计学上显著低于对照组(DMFT:平均差值 -0.72,95%置信区间(CI) -1.23至 -0.21;DMFS:平均差值 -1.52,95%CI -2.68至 -0.36(极低质量证据))。尽管这种差异具有临床意义,但仅适用于那些保留氟化物珠子的儿童;超过50%的儿童没有保留珠子。试验报告中未报告不良事件。本综述中寻求的其他结局(龋损进展、牙痛、医疗保健利用数据)的证据也未报告。
没有足够的证据来确定缓释氟化物玻璃珠的防龋效果。现有证据质量极低,并且对普通儿童的益处可能存在高估。这些发现对更广泛人群的适用性尚不清楚;该研究纳入的是来自饮用水中氟含量低的贫困地区的儿童,这些儿童被认为患龋风险高。此外,证据仅来自两年时仍附着有珠子的儿童(占所有可用儿童的48%);较早丢失缓释氟化物装置的儿童可能没有从该装置中获得那么多益处。